Bobo Donald E Jr's Form 4 filing
Edwards Lifesciences Corp (EW) · filed May 18, 2026
- Accession no.
- 0001225208-26-005463
- Filed
- May 18, 2026
- Trade date
- May 15, 2026
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.47M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bobo Donald E JrCIK 0001196661 | Officer (CVP,Strategy/Corp Development) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 15, 2026 | Common Stock | SSaleDisposed | −9,968 | $82.07 | −$818,073.76 | 22,798.25 | Direct | |
| May 15, 2026 | Common Stock | SSaleDisposed | −8,000 | $81.82 | −$654,560 | 30,969.58 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.